Oleate induces a myofibroblast-like phenotype in mesangial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 3, 2008, Pages 541-547

  Mishra, Rangnath ^a   Simonson, Michael S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosis; Free fatty acids; Mesangial cells; Microvascular; Pericytes; TGF

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ARTICLE; CELL FATE; CELL REGENERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VIVO STUDY; MESANGIUM CELL; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; PHYSIOLOGY; SECRETION; SENSITIVITY AND SPECIFICITY;

CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MESANGIAL CELLS; OLEIC ACID; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 40749159678     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.157339     Document Type: Article

References (55)

1. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res. 1996;32:687-698.
2. Sims DE. Diversity within pericytes. Clin Exp Pharmacol Physiol. 2000; 27:842-846.
3. Shepro D, Morel NM. Pericyte physiology. Faseb J. 1993;7:1031-1038.
4. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97:512-523.
5. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes. 2002;51:3107-3112.
6. Bjarnegard M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, Takemoto M, Gustafsson E, Fassler R, Betsholtz C. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development. 2004;131: 1847-1857.
7. Herman IM, Jacobson S. In situ analysis of microvascular pericytes in hypertensive rat brains. Tissue Cell. 1988;20:1-12.
8. Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum. 1999;42:930 -941.
9. Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM, Abraham DJ. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther. 2005;7:R1113-1123.
10. Schor AM, Allen TD, Canfield AE, Sloan P, Schor SL. Pericytes derived from the retinal microvasculature undergo calcification in vitro. J Cell Sci. 1990;97(Pt 3):449-461.
11. Collett G, Wood A, Alexander MY, Varnum BC, Boot-Handford RP, Ohanian V, Ohanian J, Fridell YW, Canfield AE. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res. 2003;92:1123-1129.
12. Postlethwaite AE, Shigemitsu H, Kanangat S. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol. 2004;16:733-738.
13. Ivarsson M, Sundberg C, Farrokhnia N, Pertoft H, Rubin K, Gerdin B. Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Res. 1996;229:336-349.
14. Desmouliere A, Darby IA, Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest. 2003;83:1689-1707.
15. Walker GA, Guerrero IA, Leinwand LA. Myofibroblasts: Molecular crossdressers. Curr Top Dev Biol. 2001;51:91-107.
16. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349-363.
17. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.
18. Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, Pearson JD, Dashwood M, du Bois RM, Black CM, Leask A, Abraham DJ. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell. 2004;15:2707-2719.
19. Ng CP, Hinz B, Swartz MA. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci. 2005;118: 4731-4739.
20. Jensen MD. Fate of fatty acids at rest and during exercise: regulatory mechanisms. Acta Physiol Scand. 2003;178:385-390.
21. Boden G, Shulman GI Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest. 2002;32(Suppl 3):14-23.
22. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230-1239.
23. de Jongh RT, Serne EH, Ijzerman RG, de Vries G, Stehouwer CD. Free fatty acid levels modulate microvascular function: relevance for obesityassociated insulin resistance, hypertension, and microangiopathy. Diabetes. 2004;53:2873-2882.
24. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord. 2004;28(Suppl 4):S58-65.
25. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147-152.
26. Abrass CK. Lipid metabolism and renal disease. Contrib Nephrol. 2006; 151:106-121.
27. Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol. 2000;11:669-683.
28. Zhou Y-T, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obestity. Proc Natl Acad Sci. 2000;97:1784-1789.
29. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE. The activated mesangial cell: A glomerular "myofibroblast"? J Am Soc Nephrol. 1992;2(S2):S190-S197.
30. Dai C, Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF/31 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol. 2004;15:1402-1412.
31. Lee C, Barnett J, Reaven PD. Liposomes enriched in oleic acid are less susceptible to oxidation and have less proinflammatory activity when exposed to oxidizing conditions. J Lipid Res. 1998;39:1239-1247.
32. Spector AA. Structure and lipid binding properties of serum albumin. Methods Enzymol. 1986;128:320-329.
33. Mishra R, Simonson MS. Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic sig- naling involving caspase 9 and mitochondrial release of endonuclease G. Cardiovasc Diabetol. 2005;4:2.
34. Kleinfeld AM, Prothro D, Brown DL, Davis RC, Richieri GV, DeMaria A. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Caridiol. 1996;78:1350-1354.
35. Shafrir E. Partition of unesterifed fatty acids in normal and nephrotic serum and its effect on serum electrophoretic pattern. J Clin Invest. 1958;37:1775-1783.
36. Schultz PJ, DiCorleto PE, Silver BJ, Abboud HE. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. AmJ Physiol. 1988; 255:F674-F684.
37. Mishra R, Leahy P, Simonson M. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol. 2002;283:F1151-F1159.
38. Mishra R, Emancipator SN, Miller C, Kern T, Simonson MS. Adipose differentiation related protein and regulators of lipid homeostasis identified by gene expression profiling in murine db/db diabetic kidney. Am J Phsyiol. 2004;286:F913-F921.
39. Zheng F, Fornoni A, Elliot SJ, Guan Y, Breyer MD, Striker LJ, Striker GE. Upregulation of type I collagen by TGF-/3 in mesangial cells is blocked by PPARgamma activation. Am J Physiol Renal Physiol. 2002; 282:F639-648.
40. Hayman EG, Engvall E, Ruoslahti E. Concomitant loss of cell surface fibronectin and laminin from transformed rat kidney cells. J Cell Biol. 1981;88:352-357.
41. Mishra R, Zhu L, Eckert R, Simonson MS. TGF/3-Regulated collagen type I accumulation: Role of Src-based signals. Am J Physiol Cell Physiol. 2007;292:C1361-C1369.
42. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol. 2001;159: 1313-1321.
43. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-/3 using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994;216:276-284.
44. Wang Y, Simonson MS. Voltage-insensitive Ca2+ channels and Ca2+/ calmodulin-dependent protein kinases propagate signals from endothelin-1 receptors to the c-fos promoter. MolecCellBiol. 1996;16: 5915-5923.
45. Mishra R, Leahy P, Simonson M. Gene expression profile of endothelin1-induced growth in glomerular mesangial cells. Am J Physiol. 2003;285: C1109-C1115.
46. Mishra R, Wang Y, Simonson MS. Cell cycle signaling by endothelin-1 requires Src nonreceptor protein tyrosine kinase. Mol Pharmacol. 2005; 67:2049-2056.
47. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδACT method. Methods. 2001;25: 402-408.
48. van Timmeren MM, Bakker SJ, Stegeman CA, Gans RO, van Goor H. Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis. Nephrol Dial Transplant. 2005;20:2349-2357.
49. Mason RM, Abdel Wahab N. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14:1358-1373.
50. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFβ activation. J Cell Sci. 2003;116:217-224.
51. Vacaresse N, Lajoie-Mazenc I, Auge N, Suc I, Frisach MF, Salvayre R, Negre-Salvayre A. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ Res. 1999;85:892-899.
52. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acidinduced mitogenic signaling in vascular smooth muscle cells. Circ Res. 1996;79:611-619.
53. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol Pharmacol. 2002;62:58-64.
54. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 2005;280:13285-13291.
55. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015-3025.